Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial

BACKGROUND: Sodium oxybate has been recognized as a gold standard for the treatment of disrupted nighttime sleep due to narcolepsy. Its short half-life and immediate-release formulation require patients to awaken 2.5–4 h after their bedtime dose to take a second dose. A novel extended-release, once-...

Descripción completa

Detalles Bibliográficos
Autores principales: Roth, Thomas, Dauvilliers, Yves, Thorpy, Michael J., Kushida, Clete, Corser, Bruce C., Bogan, Richard, Rosenberg, Russell, Dubow, Jordan, Seiden, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994715/
https://www.ncbi.nlm.nih.gov/pubmed/35380374
http://dx.doi.org/10.1007/s40263-022-00904-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994715/
https://www.ncbi.nlm.nih.gov/pubmed/35380374
http://dx.doi.org/10.1007/s40263-022-00904-6

Ejemplares similares